Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by 2b7f6fabon Aug 07, 2019 7:22pm
62 Views
Post# 30004438

RE:RE:RE:RE:RE:RE:RE:RE:RE:Settle down

RE:RE:RE:RE:RE:RE:RE:RE:RE:Settle downQuattro74,  I don't know if the .54c warrants get exercised or not.  Its entirely possible they will be exercised since March is like 7 months away and we should have 3 month data from at least 15 patients by then.   If this offering is overalloted then say 53 million new shares plus 53 million warrants give us a fully diluted +290 million shares.  So this offering represents 106/290 35% of the voting power.  Now if the owner of those 54 cent warrants is also participating big in this offering then we would likely have a 19.9% owner.  Change in board members and change in control of the corporation is entirely possible and soon.

Quattro74 wrote:
So we were at ~ 185Mil shares, fully diluted, prior to this prospectus. 2b7f, does your figure include the .54c warrants due in March? Or do those get wiped?

2b7f6fab wrote:
The rumor is that this Offering is fully subscribed and overallotment.  If so, then expect another +105 million shares fully diluted.   If anyone thought RW had control before it's probably gone now unless he had another $1.5 million to kick in.  I'm expecting a buyout as soon as positive news releases begin to flow.




Bullboard Posts